Daunt, A., Perez-Guzman, P. N., Liew, F., Hauck, K., Costelloe, C. E., Thursz, M. R., . . . Nayagam, S. (2020). Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease. J Infect.
Chicago Style CitationDaunt, Anna, Pablo N. Perez-Guzman, Felicity Liew, Katharina Hauck, Ceire E. Costelloe, Mark R. Thursz, Graham Cooke, and Shevanthi Nayagam. "Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir Use in Patients With COVID-19 Disease." J Infect 2020.
MLA CitationDaunt, Anna, et al. "Validity of the UK Early Access to Medicines Scheme Criteria for Remdesivir Use in Patients With COVID-19 Disease." J Infect 2020.
Warning: These citations may not always be 100% accurate.